What Does Anavex Life Sciences Corp.'s 6.35% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadlineprnewswire·Oct 23, 2026 at 05:31 PMAVXL-2.21%
What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadlineprnewswire·Oct 22, 2026 at 05:01 PMAVXL-2.21%
Anavex Completes Clinical Conduct of Two Blarcamesine Pharmacology StudiesPUBT·Oct 20, 2026 at 08:00 PMAVXL-2.21%
Buyback Cadence and Biotech Breakthroughs: Quiet Shifts in Dormant SectorsGlobal Report·Oct 20, 2026 at 10:15 AMLXEH+1.01%AVXL-2.21%
Anavex Life Sciences Gets FDA OK for Clinical Study of Genetic Disorder TreatmentMorningStar·Oct 15, 2026 at 08:59 PMAVXL-2.21%
Anavex Receives FDA Clearance for Blarcamesine Trial in Fragile X SyndromePUBT·Oct 15, 2026 at 08:00 PMAVXL-2.21%
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firmprnewswire·Oct 15, 2026 at 07:45 PMAVXL-2.21%
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Lawprnewswire·Oct 12, 2026 at 06:16 AMAVXL-2.21%
